MOTT DAVID M
Related Filers (68)
- Epizyme, Inc. (39)
- Mersana Therapeutics, Inc. (23)
- ARDELYX, INC. (19)
- AVEO PHARMACEUTICALS INC (16)
- BASKETT FOREST (15)
- Adaptimmune Therapeutics PLC (14)
- KERINS PATRICK J (13)
- TESARO, Inc. (12)
- MEDIMMUNE INC /DE (11)
- SANDELL SCOTT D (11)
- NEA 13 GP, Ltd (10)
- NEW ENTERPRISE ASSOCIATES 13 LP (10)
- NEA Partners 13, Limited Partnership (10)
- BARRIS PETER J (9)
- NOVAVAX INC (8)
- CVENT INC (7)
- IMARA Inc. (7)
- NEA Partners 14, L.P. (6)
- NEA 14 GP, LTD (6)
- APPIAN CORP (5)
- Viswanathan Ravi (5)
- New Enterprise Associates 14, L.P. (5)
- Sonsini Peter W. (5)
- Omthera Pharmaceuticals, Inc. (4)
- Roka BioScience, Inc. (4)
- SYNLOGIC, INC. (4)
- Ra Pharmaceuticals, Inc. (4)
- Tracon Pharmaceuticals, Inc. (4)
- Florence Anthony A. Jr. (4)
- Millennial Media Inc. (3)
- Workday, Inc. (3)
- Clovis Oncology, Inc. (3)
- Care.com Inc (3)
- INTERLEUKIN GENETICS INC (3)
- Cascadian Therapeutics, Inc. (3)
- Regulus Therapeutics Inc. (3)
- MULESOFT, INC (3)
- BARRETT M JAMES (3)
- GENOCEA BIOSCIENCES, INC. (3)
- Nightstar Therapeutics plc (3)
- GLYCOMIMETICS INC (2)
- Weller Harry R (2)
- DRANT RYAN D (2)
- KOLLURI KRISHNA KITTU (2)
- AEROHIVE NETWORKS, INC (2)
- Loxo Oncology, Inc. (2)
- Dermira, Inc. (2)
- BOX INC (2)
- Cerecor Inc. (2)
- Achaogen Inc (2)
- RHYTHM PHARMACEUTICALS, INC. (2)
- ARCA biopharma, Inc. (2)
- Surface Oncology, Inc. (2)
- Elastic N.V. (2)
- PhaseBio Pharmaceuticals Inc (2)
- Trevi Therapeutics, Inc. (2)
- Mirum Pharmaceuticals, Inc. (2)
- Cloudflare, Inc. (2)
- Oyster Point Pharma, Inc. (2)
- Galera Therapeutics, Inc. (2)
- Sprout Social, Inc. (2)
- CHAMPIONS ONCOLOGY, INC. (1)
- Arsanis, Inc. (1)
- Strongbridge Biopharma plc (1)
- Marker Therapeutics, Inc. (1)
- Millendo Therapeutics, Inc. (1)
- Black Diamond Therapeutics, Inc. (1)
- Casper Sleep Inc. (1)
- Show More ...
Ownership (254)
4
Thursday, 1/4/2024
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/4/2023
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/6/2023
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/3/2023
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
ARDELYX, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
NOVAVAX INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/5/2023
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2022
ARDELYX, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/16/2022
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/5/2022
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/1/2022
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
ARDELYX, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
NOVAVAX INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
NOVAVAX INC: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/3/2022
IMARA Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/19/2022
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/1/2022
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/23/2022
IMARA Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/17/2022
IMARA Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/14/2022
IMARA Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/5/2022
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/1/2021
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/24/2021
NOVAVAX INC: Statement of changes in beneficial ownership of securities
4
Friday, 7/2/2021
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Thursday, 7/1/2021
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/30/2021
IMARA Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/22/2021
NOVAVAX INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/21/2021
ARDELYX, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/15/2021
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/15/2021
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/1/2021
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/29/2021
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/20/2021
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/5/2021
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/15/2020
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/10/2020
ARDELYX, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/3/2020
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/12/2020
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/1/2020
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/28/2020
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/1/2020
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/1/2020
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Monday, 6/29/2020
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/26/2020
NOVAVAX INC: Statement of changes in beneficial ownership of securities
4
Friday, 6/26/2020
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/26/2020
ARDELYX, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/24/2020
ARDELYX, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 6/22/2020
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/18/2020
NOVAVAX INC: Initial statement of beneficial ownership of securities
4
Thursday, 6/18/2020
NOVAVAX INC: Statement of changes in beneficial ownership of securities
4
Thursday, 6/11/2020
ARDELYX, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/2/2020
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/13/2020
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/9/2020
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/2/2020
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/16/2020
IMARA Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 3/11/2020
IMARA Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 2/6/2020
Casper Sleep Inc.: Initial statement of beneficial ownership of securities
3
Wednesday, 1/29/2020
Black Diamond Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 1/28/2020
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Friday, 1/3/2020
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/3/2020
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/26/2019
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/18/2019
Sprout Social, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/12/2019
Sprout Social, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 12/9/2019
ARDELYX, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/12/2019
Galera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/6/2019
Galera Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 11/4/2019
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/30/2019
Oyster Point Pharma, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 10/2/2019
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/18/2019
Cloudflare, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/12/2019
Cloudflare, Inc.: Initial statement of beneficial ownership of securities
4/A
Wednesday, 9/11/2019
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/24/2019
Mirum Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/17/2019
Mirum Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/3/2019
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/2/2019
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/28/2019
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/26/2019
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/25/2019
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 6/17/2019
ARDELYX, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/11/2019
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/7/2019
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/7/2019
Nightstar Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Monday, 5/13/2019
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/9/2019
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 5/7/2019
Trevi Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 4/8/2019
AVEO PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/6/2019
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/19/2019
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/29/2019
Nightstar Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/22/2019
TESARO, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/4/2019
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/2/2019
Nightstar Therapeutics plc: Initial statement of beneficial ownership of securities
4
Friday, 12/21/2018
AVEO PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 12/14/2018
Ra Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities